CVX Ventures Online Partner meeting
At this partner meeting, a number of companies will be presented that you can join as advisory board members and/or invest in. The companies will be announced progressively.
Read About the Cases
Nordic Charge
At Nordic Charge, they manage a comprehensive e-mobility setup for businesses using their self-developed cloud software and automated logistics. They handle the entire process of installing charging stations in homes, businesses, and associations. Their primary customers include businesses offering service agreements to private customers, resellers like webshops and car dealerships, and public and private organizations such as housing associations and municipalities.
Initially, they focused on establishing partnerships with significant market players. They succeeded in forming more than twenty partnerships, including with Rolec, Alpitronic, and Monta. Additionally, they achieved proof of concept for their core product, the Partner Portal. Currently, they have signed agreements with two energy companies and have now started actively pursuing new clients.
Nordic charge is looking for B2B experience with an international scope, particularly experience within areas of technology/software development, funding and financing as well as experience with infrastructure and the energy sector.
NeoCare Nordic
Neo Care Nordic is at the forefront of revolutionizing neonatal care through its commitment to developing innovative solutions tailored for Neonatal Intensive Care Units (NICUs). With a focus on addressing the complex challenges faced by neonatal departments, Neo Care Nordic emphasizes a need-driven approach that integrates insights from science and design. By prioritizing the enhancement of daily workflows and ensuring the safety of neonatal infants, Neo Care Nordic aims to elevate the standards of care in NICUs. Through its dedication to excellence and advancement in clinical outcomes, Neo Care Nordic stands as a beacon of progress in the field of neonatal care.
Neo Care Nordic, a finalist in the Danish Tech Challenge, aims to become the first female-led venture to win. Additionally, the company recently won the pitch competition at The Nordic Health Lab Impact Awards in the Social Impact category. Operating with a direct sales cost structure, Neo Care Nordic sets its end-user price at 7,000 DKK, with COGS at 500 DKK and logistics/packaging costs at 165 DKK. With a distributor markup of less than 2.3, the company employs both direct and mixed channel strategies, anticipating profitability in Q3 2026 with projected revenue of 178 million DKK by 2028.
Neocare Nordic is looking for the ideal candidate with experience in regulatory affairs, patent law, negotiating license agreements, and a background in securing funding. This individual should possess expertise in navigating regulatory requirements, protecting intellectual property, negotiating agreements, and securing financial support for projects.
ZIO Health
ZiO Health, a UK MedTech company founded in 2016, is developing a hand-held biosensor to measure blood drug concentration. Their initial target is the vancomycin market, used to treat sepsis, a serious condition affecting vulnerable populations.
ZiO Health has demonstrated significant traction with its proprietary biosensor technology. Over 20 hospital systems, including UMass Memorial and University of California Irvine Medical Center, have expressed interest in conducting clinical trials for the device. ZiO has received endorsements from over 30 key opinion leaders, including consultant microbiologists and ICU clinicians. The company is expanding its product portfolio with tests for chemotherapy drugs, other antibiotics, anti-retrovirals, and opioids. Additionally, they have raised approximately £1M in grants and £3.1M in dilutive funding, with a pre-money valuation of £12M and an expected breakeven by Q3 2026.
GBP 600k is available for CVX Investors. In addition Zio has received GBP 1m worth of grants and currently has a pre money valuation of GPD 12m. The pre-money cap table is composed of CEO (42%), investors (49%) and ex-founder (9%). Round: GBP 2M in dilutive funding of which GBP 1.4M raised (led by SOSV)
Dunbar
Dunbar leverages the engaging nature of social media platforms, including TikTok, to enhance corporate training programs through microlearning. By encouraging consistent daily practice, Dunbar helps employees achieve mastery. The app motivates employees to develop and maintain small daily habits, leading to significant and lasting improvements. Dunbar connects employees with similar goals and fosters long-term motivation through quick, 60-second videos.
Dunbar’s traction includes a pilot program with CRH, an NYSE-listed and S&P 500 company. In June, CRH will test the product with a subset of their 75,000 employees. If successful, Dunbar will be rolled out across the entire corporation. This pilot aims to demonstrate Dunbar’s effectiveness in enhancing employee training and engagement. Early feedback from CRH will be crucial in refining the app and tailoring it to meet the specific needs of large organizations. A successful launch could pave the way for partnerships with other major companies.
Dunbar is looking for expertise in B2B sales, networking within large corporations, and scaling SaaS companies. The ideal candidate will have experience in driving business growth through strategic partnerships and sales efforts. They should have a proven track record of building and maintaining relationships with key stakeholders in major corporations. Additionally, experience in expanding and scaling SaaS businesses is important, focusing on increasing market share and improving sales processes. Dunbar seeks individuals who can navigate complex sales cycles and contribute to the company’s growth and success.
Exowave
Exowave has developed and patented a technology that utilizes wave energy and can convert that into green electricity and it can also be applied in ocean water desalination and secure drinking water from the oceans.
Our technology is patented for important markets around the world and we have a strong supply chain in place, strategic investors amongst. Presently we have investors from Denmark, Germany, US and Canada and we are soft funded by the Danish EUDP.
Exowave is looking for expertise in board education, international business, equity funding, and visionary leadership. We need candidates experienced in educating board members, managing global operations, advising on equity funding, and driving strategic direction with innovative ideas.
VitalSigns
VitalSigns takes the complexity out of lifesaving, making it accessible and understandable to all. They envision a future where life-saving tools are available in every home and workplace. VitalSigns has created a solution that enhances everyone’s ability to save lives. They have developed a device that acts as a CPR guide. The design fits well into homes, cars, planes, and more. It’s a universal tool, ready to save lives whenever and wherever needed.
VitalSigns has demonstrated significant market traction with key customers. The first version of their product sold out quickly, highlighting strong demand. The company has filed one patent, reinforcing their commitment to innovation. Additionally, VitalSigns offers a high-margin product with substantial pricing potential. Their engagement with academia is evident, as there are currently four ongoing Bachelor’s theses focused on their technology.
VitalSigns is seeking individuals with expertise in three key areas: scaling consumer sales within the life science industry, fundraising. They are looking for candidates with hands-on experience in growing sales operations in the life science sector, successfully securing funding through strategic relationships and investor engagement.
